Abstract
Genetically modified immunodeficient pigs support the development of functional human B and T cells and represent a preclinical model for investigating human haematopoiesis and a bioreactor for large-scale production of human immune cells for diverse therapies.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 1565-1566 |
| Number of pages | 2 |
| Journal | Nature Biomedical Engineering |
| Volume | 9 |
| Issue number | 10 |
| DOIs |
|
| State | Published - Oct 2025 |
Bibliographical note
Publisher Copyright:© Springer Nature Limited 2025.
PubMed: MeSH publication types
- Journal Article